Article Versions Notes

García-Ros A, Morán S, Núñez V, García-Ros G, Ruiz G, García-Solano J. Impact of Direct-Acting Antiviral Therapy on Liver Fibrosis Regression among People with Chronic HCV Infection: Results from a Real-Life Cohort in Patients Who Achieved Sustained Virological Response. Medicina. 2023; 59(4):814. https://doi.org/10.3390/medicina59040814

García-Ros, Alejandro, Senador Morán, Virginia Núñez, Gonzalo García-Ros, Guadalupe Ruiz, and José García-Solano. 2023. "Impact of Direct-Acting Antiviral Therapy on Liver Fibrosis Regression among People with Chronic HCV Infection: Results from a Real-Life Cohort in Patients Who Achieved Sustained Virological Response" Medicina 59, no. 4: 814. https://doi.org/10.3390/medicina59040814

García-Ros, A., Morán, S., Núñez, V., García-Ros, G., Ruiz, G., & García-Solano, J. (2023). Impact of Direct-Acting Antiviral Therapy on Liver Fibrosis Regression among People with Chronic HCV Infection: Results from a Real-Life Cohort in Patients Who Achieved Sustained Virological Response. Medicina, 59(4), 814. https://doi.org/10.3390/medicina59040814